Treating Obstructive Sleep Apnea and Snoring: Assessment Of

Clark, Glenn T.; Sohn, Jin-Woo; Hong, Cuong N.

doi:10.14219/jada.archive.2000.0275

Cited by 102 publications

(101 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pancer, AlFaifi & Hoffstein (1999) 20 reported dental discomfort some times or with frequency in more than 32% of patients. According to Clark, Sohn & Hong (2000) 3 , 38% of patients reported suffering from toothache. For O'Sullivan (1995) 5 , the main effect reported was medium discomfort in the dental arcs when waking up, with reduction of the symptom in three weeks, in most cases.…”

Section: Discussionmentioning

confidence: 99%

“…1,2 This syndrome affects as many as 4% of the adult population, being more predominant in men, increasing from the 5th life decade onwards 3,4 . Patients with OSAH have significantly more hypertension, ischemic heart disease and brain vascular disease than individuals without the syndrome.…”

Section: Introductionmentioning

confidence: 99%

“…), through a flexible tube to a nasal mask tightly strapped to the patient's face. 3,11 . According to Sullivan et al 5 , although the treatment of obstructive sleep apnea with CPAP is highly effective, it is little tolerated by approximately 36% of patients, specially by those with medium severity.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Tratamento da síndrome da apnéia e hipopnéia obstrutiva do sono com aparelhos intrabucais

Almeida¹,

Teixeira

Vieira

et al. 2006

Rev. Bras. Otorrinolaringol.

View full text Add to dashboard Cite

Obst ructive sleep apnea and hipoapnea syndrome (OSAHS) is a disorder that affects about 4% of the adult population, and besides the social problems associated to snoring and extreme day time sleepiness, it is preoccupying since it may cause pulmonary hypertension and cardiac failure. Review and discussion -Through a literature review, we discuss the use of oral appliances to treat this condition, in regards of therapy effectiveness and limitations, main clinical symptoms, major occlusal side effects, rate of improvement and patient satisfaction. Conclusions -We concluded that the use of oral appliances should be a first choice treatment for mild to moderate OSAHS, being dental, joint and muscular discomforts, hypersalivation and xerostomia, the most frequent clinical symptoms, with light occlusal side effects that normally do not bother the patients, with a good degree of improvement and high satisfaction index.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Tratamento da síndrome da apnéia e hipopnéia obstrutiva do sono com aparelhos intrabucais

Almeida¹,

Teixeira

Vieira

et al. 2006

Rev. Bras. Otorrinolaringol.

View full text Add to dashboard Cite

show abstract

“…Treatment adherence could not be objectively verified. Clark et al, 2000 A more aggressive post-insertion recall program might have substantially increased the adherence to treatment. A majority of patients elected not to follow the authors' advice and participate in a second, post-appliance sleep study.…”

Section: 5%mentioning

confidence: 99%

Temporomandibular Disorders in Patients Undergoing Mandibular Advancement Device Therapy for Obstructive Sleep Apnea: A Systematic Review

Nguyen¹,

Balasubramaniam²

2016

AJOM

View full text Add to dashboard Cite

Background: Mandibular advancement device (MAD) therapy is a popular and effective treatment for snoring and obstructive sleep apnea (OSA). However, there have been several reports in the literature of patients developing temporomandibular disorders (TMDs). Objective:The objective of this review is to evaluate the prevalence of TMD, both in the initial phase of therapy and at follow up appointments, amongst patients wearing a MAD for OSA. Methods:The authors conducted a systematic review of published articles in which the presence of TMDs in patients undergoing MAD therapy for OSA was investigated. Eligible studies met the following criteria: a diagnosis of TMD following mandibular advancement using a custom-made and titratable MAD using either the Diagnostic Criteria for TMD (DC/TMD), Helkimo Anamnestic Dysfunction Index or reproducible clinical signs/symptoms. Of the thirty-six articles published in this area, eleven were included in this review. These were assessed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Results:The average prevalence of TMD during the initial phase of MAD therapy was found to be 25%. The prevalence of TMD reduced in the follow up periods. The adherence to MAD, especially long term, appears to be variable and from our results, it appears an average of 20% of patients discontinue MAD therapy over six to one hundred and twenty months, and this number has been reported to be as high as 62.5% (over 58 months). Conclusions:There was some difficulty in comparing the studies due to the differences in follow up time, methodology, sample size and diagnostic criteria. Longer clinical follow-up studies, with an objective method of monitoring patient adherence such as home monitoring devices, and preferably with a larger sample size Amanda Phoon Nguyen and Ramesh Balasubramaniam / American Journal of Oral Medicine (2016) Vol. 2 No. 1 pp. 26-42 27 are needed to evaluate the long-term effects of MADs on the TMD. The authors consider it prudent for clinicians to counsel patients that a small number will experience signs and symptoms of TMD with MAD use. However TMD is usually transient and the long-term risk appears small. In patients who develop TMD during MAD therapy, treatment of their TMD is recommended to prevent discontinuation of MAD therapy. In a few patients, persistent TMD may result in discontinuation of MAD therapy. Patients should be cautioned of this possibility and subsequently referred to consider other treatment options for their OSA.

show abstract

“…This is known as oral appliance therapy (Clark et al 2000;Hosoya et al 2014;Bender 2016;Lavigne and Sessle 2016). At present, obstructive sleep apnea is principally believed to be associated with a narrowed upper airway (Dudley and Patel 2016;Kassim et al 2016).…”

Section: Introductionmentioning

confidence: 99%

Gustatory Salivation Is Associated with Body Mass Index, Daytime Sleepiness, and Snoring in Healthy Young Adults

Izumi

Hong

Iwasaki³

et al. 2016

Tohoku J. Exp. Med.

View full text Add to dashboard Cite

The taste detection system for oral fatty acid may be related to obesity. In addition, sleep is intrinsically and closely related to food intake and metabolism. However, the association of gustatory salivation with body mass index (BMI), daytime sleepiness, or sleep habits is largely unknown. Therefore, we evaluated the relationship between gustatory salivation and BMI, Epworth sleepiness scale (ESS, a daytime sleepiness scale) or sleep habits among 26 healthy young individuals (20 males and 6 females; mean age: 26.0 ± 4.3 years). We also measured the saliva flow rate (SFR) that was induced by gum-chewing or each of three prototypical tastants (acetic acid, sucrose, and NaCl). Further, the SFR was induced by fatty acid, provided as oleic acid (OA) homogenized in non-fat milk. All participants showed normal rates of salivation during resting and gum-chewing states. The increase in the SFR induced by OA, but not by each of the three tastants, was associated with BMI. Moreover, both daytime sleepiness level and frequency of snoring were associated with the increase in the SFR induced by NaCl. These results suggest that BMI is associated with salivation induced by oral fatty acid exposure. Additionally, the regulatory mechanism for the NaClinduced salivation reflex may have a relationship with impairments of the respiratory control system that are related to snoring during sleep and lead to daytime sleepiness because of insufficient sleep. Thus, measurement of gustatory salivation might contribute to the evaluation and prevention of obesity and sleeprelated breathing disorders.

show abstract

Treating Obstructive Sleep Apnea and Snoring: Assessment Of

Cited by 102 publications

References 16 publications

Tratamento da síndrome da apnéia e hipopnéia obstrutiva do sono com aparelhos intrabucais

Tratamento da síndrome da apnéia e hipopnéia obstrutiva do sono com aparelhos intrabucais

Temporomandibular Disorders in Patients Undergoing Mandibular Advancement Device Therapy for Obstructive Sleep Apnea: A Systematic Review

Gustatory Salivation Is Associated with Body Mass Index, Daytime Sleepiness, and Snoring in Healthy Young Adults

Contact Info

Product

Resources

About